BJOG An International Journal of Obstetrics & Gynaecology · 1980 · 65 citations · 12 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyPain ManagementWomen's Health PharmacotherapyMenstrual Disorder ManagementPremenstrual DisordersPremenstrual SyndromeReproductive Endocrinology PharmacotherapySide EffectsDouble-blind TrialsMenstrual Disorder PharmacotherapyMenstrual SymptomsPharmacologic AnalgesiaPremenstrual Physical SymptomsPremenstrual SymptomatologyPremenstrual Syndrome PharmacotherapyPremenstrual Syndrome Treatment
Thirty-seven patients suffering from premenstrual symptoms were each studied through three menstrual cycles. After a control cycle, mefenamic acid and placebo were given during the luteal phase of the cycle in a random double-blind cross over manner, each patient serving as her own control. The dosage of mefenamic acid was 500 mg thrice daily. Medication significantly improved premenstrual symptoms, particularly tension, irritability, depression, pain and headache. It was not effective for breast symptoms. Most patients complaining of premenstrual symptoms also had menstrual symptoms, which were also improved by the mefenamic acid.
12
Radioimmunoassay of the F Prostaglandins
Burton V. Caldwell, Sumner Burstein, William A. Brock et al. · The Journal of Clinical Endocrinology & Metabolism · 1971 · 265 citations
REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS
AnneB.M. Anderson, John Guillebaud, P. J. Haynes et al. · The Lancet · 1976 · 156 citations
Medicine, Gynecology, Pharmacology +12
Isolation and Identification of Two Smooth Muscle Stimulants from Menstrual Fluid
G. Eglinton, R. A. Raphael, G.N. Smith et al. · Nature · 1963 · 103 citations · Full text